Influence of prior opioid exposure on diagnostic facet joint nerve blocks

Journal of Opioid Management

Volumn 4, Issue 6, 2008, Pages 351-360

  Manchikanti, Laxmaiah ^a,d   Boswell, Mark V ^b   Manchukonda, Rajeev ^a   Cash, Kimberly A ^a   Giordano, James ^c,e  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d University of Louisville School of Medicine   (United States)

^e POTOMAC INSTITUTE FOR POLICY STUDIES   (United States)

Author keywords

Bupivacaine; Chronic spinal pain; Controlled diagnostic blocks; Facet joint blocks; Facet joint pain; False positive rates; Lidocaine; Opioids; Prevalence

Indexed keywords

BUPIVACAINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; LIDOCAINE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE; TRAMADOL;

ADULT; AGED; ANALGESIA; ARTICLE; BODY MOVEMENT; CERVICAL SPINE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EXPOSURE; FALSE POSITIVE RESULT; FEMALE; HUMAN; LOCAL ANESTHESIA; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NERVE BLOCK; PAIN ASSESSMENT; PREVALENCE; REST; SPINAL PAIN; THORACIC SPINE; VALIDITY;

EID: 58249107986     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2008.0039     Document Type: Article

References (70)

1. Trescot AM, Boswell MV, Atluri SL, et al.: Opioid guidelines in the management of chronic non-cancer pain. Pain Physician. 2006; 9(1): 1-40.
2. Manchikanti L: National drug control policy and prescription drug abuse: Facts and fallacies. Pain Physician. 2007; 10(3): 399-424.
3. Boswell MV, Trescot AM, Datta S, et al.: Interventional techniques: Evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician. 2007; 10(2): 7-111.
4. Cohen SP, Raja SN: Pathogenesis, diagnosis and treatment of lumbar zygapophysial (facet) joint pain. Anesthesiology. 2007; 106(3): 591-614.
5. Hogan QH, Abram SE: Neural blockade for diagnosis and prognosis: A review. Anesthesiology. 1997; 86(1): 216-241.
6. Cohen SP, Larkin T, Chang A, et al.: The causes of false-positive medial branch blocks in soldiers and retirees. Mil Med. 2004; 169(10): 781-786.
7. Bogduk N: International Spinal Injection Society guidelines for the performance of spinal injection procedures. Part 1: Zygapophyseal joint blocks. Clin J Pain. 1997; 13(4): 285-302.
8. Manchikanti L, Singh V, Pampati V, et al.: Evaluation of the relative contributions of various structures in chronic low back pain. Pain Physician. 2001; 4(4): 308-316.
9. Manchikanti L, Boswell MV, Singh V, et al.: Prevalence of facet joint pain in chronic spinal pain of cervical, thoracic, and lumbar regions. BMC Musculoskelet Disord. 2004; 28(5): 15.
10. Manchukonda R, Manchikanti KN, Cash KA, et al.: Facet joint pain in chronic spinal pain: An evaluation of prevalence and false-positive rate of diagnostic blocks. J Spinal Disord Tech. 2007; 20(7): 539-545.
11. Schwarzer AC, Aprill CN, Derby R, et al.: Clinical features of patients with pain stemming from the lumbar zygapophysial joints. Is the lumbar facet syndrome a clinical entity? Spine. 1994; 19(10): 1132-1137.
12. Schwarzer AC, Aprill CN, Derby R, et al.: The relative contributions of the disc and zygapophysial joint in chronic low back pain. Spine. 1994; 19(7): 801-806.
13. Schwarzer AC, Wang SC, Bogduk N, et al.: Prevalence and clinical features of lumbar zygapophysial joint pain: A study in an Australian population with chronic low back pain. Am Rheum Dis. 1995; 54(2): 100-106.
14. Manchikanti L, Pampati V, Fellows B, et al.: Prevalence of lumbar facet joint pain in chronic low back pain. Pain Physician. 1999; 2(3): 59-64.
15. Manchikanti L, Pampati V, Fellows B, et al.: The diagnostic validity and therapeutic value of medial branch blocks with or without adjuvant agents. Curr Rev Pain. 2000; 4(5): 337-344.
16. Manchikanti L, Pampati V, Fellows B, et al.: The inability of the clinical picture to characterize pain from facet joints. Pain Physician. 2000; 3(2): 158-166.
17. Manchikanti L, Hirsch JA, Pampati V: Chronic low back pain of facet (zygapophysial) joint origin: Is there a difference based on involvement of single or multiple spinal regions? Pain Physician. 2003; 6(4): 399-405.
18. Manchikanti L, Singh V, Pampati V, et al.: is there correlation of facet joint pain in lumbar and cervical spine? Pain Physician. 2002; 5(4): 365-371.
19. Manchikanti L, Manchukonda R, Pampati V, et al.: Prevalence of facet joint pain in chronic low back pain in post-surgical patients by controlled comparative local anesthetic blocks. Arch Phys Med Rehabil. 2007; 88(4): 449-455.
20. Barnsley L, Lord SM, Wallis BJ, et al.: The prevalence of chronic cervical zygapophyseal joint pain after whiplash. Spine. 1995; 20(1): 20-26.
21. Lord SM, Barnsley L, Wallis BJ, et al.: Chronic cervical zygapophysial joint pain with whiplash: A placebo-controlled prevalence study. Spine. 1996; 21(15): 1737-1745.
22. Manchikanti L, Singh V, Rivera J, et al.: Prevalence of cervical facet joint pain in chronic neck pain. Pain Physician. 2002; 5(3): 243-249.
23. Speldewinde GC, Bashford GM, Davidson IR: Diagnostic cervical zygapophyseal joint blocks for chronic cervical pain. Med J Aust. 2001; 174(4): 174-176.
24. Manchikanti L, Singh V, Falco FJ, et al.: Cervical medial branch blocks for chronic cervical facet joint pain: A randomized double-blind, controlled trial with one-year follow-up. Spine. 2008; 33(17): 1813-1820.
25. Manchikanti L, Singh V, Pampati V, et al.: Evaluation of the prevalence of facet joint pain in chronic thoracic pain. Pain Physician. 2002; 5(4): 354-359.
26. Schwarzer AC, Aprill CN, Derby R, et al.: The false-positive rate of uncontrolled diagnostic blocks of the lumbar zygapophysial joints. Pain. 1994; 58(2): 195-200.
27. Barnsley L, Lord S, Wallis B, et al.: False-positive rates of cervical zygapophysial joint blocks. Clin J Pain. 1993; 9(2): 124-130.
28. Carragee EJ, Haldeman S, Hurtwitz F: The pyrite standard: The Midas touch in the diagnosis of axial pain syndromes. Spine J. 2007; 7(1): 27-31.
29. Carragee EJ: Is lumbar discography a determinate of discogenic low back pain: Provocative discography reconsidered. Curr Rev Pain. 2000; 4(4): 301-308.
30. Carragee EJ, Chen Y, Tanner CM, et al.: Provocative discography in patients after limited lumbar discectomy. A randomized study of pain response in symptomatic and asymptomatic subjects. Spine. 2000; 25(23): 3065-3071.
31. Carragee EJ, Tanner CM, Khurana S, et al.: The rates of false-positive lumbar discography in select patients without low back symptoms. Spine. 2000; 25(11): 1373-1381.
32. Cohen SP, Mullings R, Abdi S: The pharmacologic treatment of muscle pain. Anesthesiology. 2004; 101(2): 495-526.
33. Manchikanti L, Singh V, Pampati V, et al.: Provocative discography in low back pain patients with or without somatization disorder: A randomized, prospective evaluation. Pain Physician. 2001; 4(3): 227-239.
34. Manchikanti L, Pampati V, Fellows B, et al.: Influence of psychological factors on the ability of diagnose chronic low back pain of facet joint origin. Pain Physician. 2001; 4(4): 349-357.
35. Manchikanti L, Damron KS, Rivera J, et al.: Evaluation of effect of sedation as a confounding factor in the diagnostic validity of lumbar facet joint pain: A prospective, randomized, double-blind, placebo-controlled evaluation. Pain Physician. 2004; 7(4): 411-417.
36. Manchikanti L, Pampati V, Damron KS, et al.: A randomized, prospective, double-blind, placebo-controlled evaluation of the effect of sedation on diagnostic validity of cervical facet joint pain. Pain Physician. 2004; 7(3): 301-309.
37. Manchikanti L, Pampati V, Damron KS, et al.: The effect of sedation on diagnostic validity of facet joint nerve blocks: An evaluation to assess similarities in population with involvement in cervical and lumbar regions. Pain Physician. 2006; 9(1): 47-52.
38. Manchikanti L, Pampati V, Damron K: The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician. 2005; 8(4): 349-355.
39. Andersen G, Sjogren P, Hansen SH, et al.: Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic nonmalignant pain. Eur J Pain. 2004; 8(3): 263-271.
40. Ballantyne J, Mao J: Opioid therapy for chronic pain. N Engl J Med. 2003; 349(20): 1943-1953.
41. Ballantyne JC: Opioid analgesia: Perspectives on right use and utility. Pain Physician. 2007; 10(3): 479-491.
42. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and opiate tolerance: A current view of their possible interactions. Pain. 1995; 62(3): 259-274.
43. Mao J, Price DD, Mayer DJ: Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C. J Neurosci. 1994; 14(4): 2301-2312.
44. Angst MS, Koppert W, Pahl I, et al.: Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003; 106(1/2): 49-57.
45. Wilson GR, Reisfield GM: Morphine hyperalgesia: A case report. Am J Hosp Palliat Care. 2003; 20(6): 459-461.
46. Kissin I: Tolerance to opioid analgesia: Why do we differ from rats? Anesth Anal. 2005; 101(6): 1727-1729.
47. Van Elstraete AC, Sitbon P, Trabold F, et al.: A single dose of intrathecal morphine in rats induces long-lasting hyperalgesia: The protective effect of prior administration of ketamine. Anesth Analg. 2005; 101(6): 1750-1756.
48. Mao J: Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain. 2002; 100(3): 213-217.
49. Mercadante S, Ferrera P, Villari P, et al.: Hyperalgesia: An emerging iatrogenic syndrome. J Pain Symptom Manag. 2003; 26(2): 769-775.
50. Angst MS, Clark JD: Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiol. 2006; 104(3): 570-587.
51. Mayer DJ, Mao J, Holt J, et al.: Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. PNAS, USA. 1999; 96(14): 7731-7736.
52. Belanger S, Ma W, Chabot JG, et al.: Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience. 2002; 115(2): 441-453.
53. Gardell LR, Wang R, Burgess SE, et al.: Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci. 2002; 22(15): 6747-6755.
54. Sharar RG. General principles of epidemiology. In Cassens BJ (ed): Preventive Medicine and Public Health. Baltimore: Williams & Wilkins, 1992, pp 1-28.
55. Boswell MV, Trescot AM, Datta S, et al.: Interventional techniques: Evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician. 2007; 10(1): 7-111.
56. Manchikanti L, Damron KS, McManus CD, et al.: Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician. 2004; 7(4): 431-437.
57. Vogt MT, Kwoh CK, Cope DK, et al.: Analgesic usage for low back pain: Impact on health care costs and service use. Spine. 2005; 30(9): 1075-1081.
58. Mahmud MA, Webster BS, Courtney TK, et al.: Clinical management and the duration of disability for work-related low back pain. J Occup Environ Med. 2000; 42(12): 1178-1187.
59. Webster BS, Verma SK, Gatchel RJ: Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine. 2007; 32(19): 2127-2132.
60. Sehgal N, Shah RV, McKenzie-Brown AM, et al.: Diagnostic utility of facet (zygapophysial) joint injections in chronic spinal pain: A systematic review of evidence. Pain Physician. 2005; 8(2): 211-224.
61. Sehgal N, Dunbar EE, Shah RV, et al.: Systematic review of diagnostic utility of facet (zygapophysial) joint injections in chronic spinal pain: An update. Pain Physician. 2007; 10(1): 213-228.
62. Barnsley L, Bogduk N: Medial branch blocks are specific for the diagnosis of cervical zygapophyseal joint pain. Reg Anesth. 1993; 18(6): 343-350.
63. Dreyfuss P, Schwarzer AC, Lau P, et al.: Specificity of lumbar medial branch and 15 dorsal ramus blocks. Spine. 1997; 22(8): 895-902.
64. Kaplan M, Dreyfuss P, Halbrook B, et al.: The ability of lumbar medial branch blocks to anesthetize the zygapophysial joint. Spine. 1998; 23(17): 1847-1852.
65. Bogduk N, Lord S: Cervical zygapophysial joint pain. Neurosurg Q. 1998; 8(2): 107-117.
66. Bonica JJ, Buckley FP (eds.): Regional analgesia with local anesthetics. In The Management of Pain. Philadelphia: Lea & Febiger, 1990, pp 1883-1966.
67. Boas RA: Nerve blocks in the diagnosis of low back pain. Neurosurg Clin N Am. 1991; 2(4): 806-816.
68. Barnsley L, Lord S, Bogduk N: Comparative local anesthetic blocks in the diagnosis of cervical zygapophysial joints pain. Pain. 1993; 55(1): 99-106.
69. Lord SM, Barnsley L, Bogduk N: The utility of comparative local anesthetic blocks versus placebo-controlled blocks for the diagnosis of cervical zygapophysial joint pain. Clin J Pain. 1995; 11(3): 208-213.
70. Manchikanti L, Singh V, Derby R, et al.: Reassessment of evidence synthesis of occupational medicine practice guidelines for interventional pain management. Pain Physician. 2008; 11(4): 393-482.